Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating isolated hepatic perfusion with melphalan followed by combination chemotherapy for patients with unresectable liver metastases from col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED